ScholarLens Back to search
2008•The Journal of Clinical PsychiatryRequires access

A clinical analysis of aripiprazole in the treatment of naive senile schizophrenia

Li Hon

Open publisher page 0 citations

Abstract

Objective:To compare the efficacy and safety between aripiprazole and haloperidol in the treatment of naive senile schizophreniaMethod:Sixty naive senile schizophrenia were randomly divided into aripiprazole group(aripiprazole treatment)or haloperidol group(haloperidol treatment)for 8 weeks.The positive and negative syndrome scale(PANSS)and the treatment emergent symptom scale(TESS)were used to assess the efficacy and the side effects.Results:There was no significant difference in the clinical efficacy between aripiprazole and haloperidol treatment.The patients in aripiprazole group had mild side effects.Conclusion:Aripiprazole has a good efficacy and high safety in the treatment of naive senile schizophrenia,which is favorable for long-term maintain treatment.

About this research paper

What this paper is about

Objective:To compare the efficacy and safety between aripiprazole and haloperidol in the treatment of naive senile schizophreniaMethod:Sixty naive senile schizophrenia were randomly divided into aripiprazole group(aripiprazole treatment)or haloperidol group(haloperidol treatment)for 8 weeks.The positive and negative syndrome scale(PANSS)and the treatment emergent symptom scale(TESS)were used to assess the efficacy and the side effects.Results:There was no significant difference in the clinical efficacy between aripiprazole and haloperidol treatment.The patients in aripiprazole group had mild side effects.Conclusion:Aripiprazole has a good efficacy and high safety in the treatment of naive senile schizophrenia,which is favorable for long-term maintain treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the efficacy and safety between aripiprazole and haloperidol in the treatment of naive senile schizophreniaMethod:Sixty naive senile schizophrenia were randomly divided into aripiprazole group(aripiprazole treatment)or haloperidol group(haloperidol treatment)for 8 weeks.The positive and negative syndrome scale(PANSS)and the treatment emergent symptom scale(TESS)were used to assess the efficacy and the side effects.Results:There was no significant difference in the clinical efficacy between aripiprazole and haloperidol treatment.The patients in aripiprazole group had mild side effects.Conclusion:Aripiprazole has a good efficacy and high safety in the treatment of naive senile schizophrenia,which is favorable for long-term maintain treatment.

Key concepts: Aripiprazole, Haloperidol, Schizophrenia (object-oriented programming), Clinical efficacy, Psychology, Positive and Negative Syndrome Scale, Medicine, Risperidone

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A clinical analysis of aripiprazole in the treatment of naive senile schizophrenia — Research Paper | ScholarLens